UPC Analytics
ENDE
Overview · Filed: Aug 26, 2025

UPC_CoA_796/2025

BIOTELEMETRY DEVICE THAT CAN BE INGESTED AND IMPLANTED IN VIVO

AppealsMain AppealCourt of AppealAppealCase Closed
  • 2025-09-16Dismissedappeal_epoAction against the decision of the EPO (RoP97)

    Court of Appeal dismissed Bodycap's appeal against the EPO's decision to reject the request for unitary effect. The CoA held that the application to annul the EPO's decision was groundless: the one-month period to correct deficiencies in a request for unitary effect (R.7(3) UPR) is non-extendable and expressly excluded from re-establishment of rights under R.22(6) UPR. Furthermore, interlocutory revision by the EPO (R.91 RoP) was excluded because the action under R.97 RoP constitutes an expedited action falling under the exception in R.85(2) RoP.

  • 2025-09-16Dismissedappeal_epoAction against the decision of the EPO (RoP97)

    French-language signed version of the Court of Appeal's decision in Bodycap v. EPO. Identical in substance to the English version: Bodycap's appeal was dismissed as groundless. The EPO's rejection of the unitary effect request was upheld because the one-month correction period is non-extendable and re-establishment of rights is excluded by R.22(6) UPR.